previous post) is angry about Tanya Luhrmann's article in The New York Times (see his video post on Medscape Psychiatry). He's worried that people reading Luhrmann's article may think they don't have a mental illness when they do and, thereby, not get the treatment they need. He's also clear, despite what Luhrmann says, that antipsychotic drugs correct a biological abnormality. He must know that he can't say psychosis is due to dopamine hyperactivity, just because antipsychotics may block dopamine, so I don't understand what he means. I do agree with him, though, that it's stretching a point to align Thomas Insel's rejection of DSM-5 (see previous post) with the thesis of the BPS report on psychosis (see another previous post). Insel is still very much a biological psychiatrist (e.g. see another previous post).
Lieberman is indignant that he has to deal with an anthropologist, like Luhrmann, commenting on such a "disciplined, bound in evidence, and scientifically anchored" subject such as psychiatry. Luhrmann in fact studied psychiatry by participant observation in her excellent book Of two minds. What Lieberman finds difficult is any scepticism about the effectiveness of psychotropic medication. As he says, debate about this issue should be encouraged.